Ocular Therapeutix (OCUL) Misses Q1 EPS by 9c

Ocular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.40), $0.09 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $10.78 million versus the consensus estimate of $12.72 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Stripe, Advent In Talks To Buy Paypal - WSJ
• AI/ML Innovations plans $2M private placement on the CSE